U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06805552) titled 'Sarcopenia and Systemic Therapy in HCC' on Jan. 28.
Brief Summary: This is a multi-center, retrospective observational study in patients with liver cancer (HCC) to assess the impact of sarcopenia (muscle loss) on the prognosis, duration, and tolerance of systemic treatment.
Study Start Date: Oct. 19, 2022
Study Type: OBSERVATIONAL
Condition:
HCC - Hepatocellular Carcinoma
Recruitment Status: RECRUITING
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Published by HT Digital Content Services with permission from Health Daily Digest....